Amanote Research
Register
Sign In
Figure 5: Six Samples Through Freeze Drying to Compound With Five Gradient Concentrations (0.0 Mg/mL, 0.2 Mg/mL, 0.4 Mg/mL, 0.6 Mg/mL, 0.8 Mg/mL, 1.0 Mg/mL) , Use the Ascorbic Acid (Vc) as the Control.
doi 10.7717/peerj.8978/fig-5
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Control of Lice Infestation in Horses Using a 10 Mg/mL Deltamethrin Topical Application
Irish Veterinary Journal
Veterinary
Volumizing Effects of a Smooth, Highly Cohesive, Viscous 20-Mg/mL Hyaluronic Acid Volumizing Filler: Prospective European Study
BMC Dermatology
Dermatology
TCH-016 Extended Chemical-Physical Stability of 25 Mg/Ml Azacitidine Suspension: Abstract TCH-016 Table 1
European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
ML-236A, ML-236B, and ML-236C, New Inhibitors of Cholesterogensis Produced by Penicillium Citrinum.
Journal of Antibiotics
Drug Discovery
Pharmacology
Controle De Qualidade De Soluções Orais De Dipirona Sódica 500 Mg/mL Referência, Genérico E Similar Comercializadas Em Gurupi-To
Amazônia Science & Health
The Effect of Switching Patients With Symptomatic Benign Prostatic Hyperplasia From Tamsulosin 0.2 Mg to 0.4 Mg
Open Journal of Urology
Long-Term Stability of a Patient-Convenient 1 Mg/Ml Suspension of Tacrolimus for Accurate Maintenance of Stable Therapeutic Levels
Bone Marrow Transplantation
Transplantation
Hematology
Preclinical and Clinical Properties of Bezlotoxumab (ZINPLAVA® 25 Mg/mL Concentrate for Solution for Infusion), Novel Therapeutic Agent for Clostridium Difficile Infection
Folia Pharmacologica Japonica
Pharmacology
Information Flow Inference for ML
ACM SIGPLAN Notices
